Key points are not available for this paper at this time.
The incidence of diabetes is increasing, but that of diabetic retinopathy is falling, probably owing to better management of glucose levels, lipid abnormalities, and hypertension. Clinical trials of VEGF and PPAR-α inhibitors are improving vision and providing insights into pathogenesis.
Building similarity graph...
Analyzing shared references across papers
Loading...
David A. Antonetti
Ronald Klein
Thomas W. Gardner
New England Journal of Medicine
University of Michigan
Building similarity graph...
Analyzing shared references across papers
Loading...
Antonetti et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d7214f3f906f6a06bef456 — DOI: https://doi.org/10.1056/nejmra1005073
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: